Navigation Links
Leading Animal Stem Cell Developer MediVet-America Achieves Significant Business Growth Milestones in First Year
Date:2/4/2011

NICHOLASVILLE, Ky., Feb. 4, 2011 /PRNewswire/ -- MediVet-America, the leading developer of in-clinic stem cell regenerative therapy for animals suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries and similar ailments, ended its first year of business having achieved record advances in size and scope.

Using MediVet-America's new Adipose-Derived Stem Cell Procedure Kit and equipment, veterinary practitioners perform the drug-free procedure entirely in their own clinics, in one day, more quickly, effectively and economically than first-generation animal stem cell therapy.

This new treatment, previously only available in Australia and New Zealand, was launched in the United States, Canada, South America and Hong Kong in 2010.

Over the past year, MediVet-America has signed agreements with more than 100 leading veterinarians and clinics, 12 distributor territories in 20 states and four provinces in Canada, providing vets with the ability to perform in-house stem cell procedures that can lengthen and rejuvenate the quality of life for adult dogs, cats and horses experiencing lameness, pain, and a restricted range of motion.  Before stem cell therapy, veterinarians were limited to prescribing anti-inflammatory medicine or performing expensive surgery.

In December, the company launched MediVet Lab Services in Lexington, KY, that provides technical support for in-clinic animal stem cell procedures, regional and national Adipose Stem Cell Processing, Cryogenic Banking Services, Autologous Conditional Serum Processing, and Cell Counting Services for stem cell treatments.

MediVet-America Managing Director Jeremy Delk envisions opening additional labs throughout the U.S. that will also provide an interactive web site with an online vet certification program and a quality assurance/control program encompassing cell counts and sterility.

"We experienced a tremendous year of growth in all areas of our business," said Delk.  "We're overwhelmed by the enthusiastic response we've received from pet owners and veterinarians around the world, and we're deeply honored by the pet industry's acknowledgement of our services.

"Excitement for the technology continues to grow; we are now seeing stem cell procedures happening every day for the past two months."

ABOUT MEDIVET-AMERICAA research and development company and global leader in veterinary stem cell technology, MediVet-America provides innovative cell applications for the therapeutic care of animals.  Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. www.MediVet-America.comCONTACT:

Dick RobertsRoberts Communicationso:  412-535-5000  c:  412-721-7400droberts@rob-com.com
'/>"/>

SOURCE MediVet-America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services
2. Leading Scientific Laboratory Offers New Methods for Metals Testing
3. Leading Dental Stem Cell and Regenerative Medicine Researcher Dr. George Huang Joins StemSaves Science Advisory Council
4. Elsevier brings together leading experts from around the world for DIAMOND 2011 conference
5. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
6. Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players
7. UBM Medica Acquires Leading Online Community OBGYN.net
8. Molecular Detections Detect-Ready™ MRSA Assay Demonstrates Strong Performance In Independent Comparative Study From Leading UK Hospital
9. Leading Journal Turns Up the Heat on Cutting-Edge Breast Cancer Treatment
10. Waters Corporation and UCLA to Convene Leading Life Scientists
11. Viscira Delivers Key Presentation to Pharmaceutical Marketing Professionals at Leading Digital Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... and MENLO PARK, Calif. , ... DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on ... that it will present at the 18 th ... 8, 2016 at 10:00 a.m. EST in New ... DelMar,s president and CEO, will provide an update on the ...
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today provided ... Uniden in the Northern District of Texas ... forward.  Inter Partes Re-examination ("IPR") ... Patent Office.  The IPR was initiated on only certain ...
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
Breaking Biology Technology:
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 /PRNewswire/ ... sensor-based diagnostic products, today announced the closing of a $9 ... investors.  Proceeds from the financing will be used to accelerate ... device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has been ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
(Date:1/6/2016)... Jan. 6, 2016 Based on its ... & Sullivan recognizes MorphoTrak, LLC, a U.S. subsidiary ... Frost & Sullivan Company of the Year Award. ... technology, Morpho Wave™ , has consolidated the company,s ... biometrics market. Morpho Wave is a highly ...
Breaking Biology News(10 mins):